We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$512M
AUM Growth
+$15.2M
Cap. Flow
-$35M
Cap. Flow %
-6.83%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.82M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$34.8M
2
SLTM
SOLTA MED INC (DE)
SLTM
+$2.01M

Sector Composition

Rank Sector Weight
1 Healthcare 31.57%
2 Consumer Staples 21.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
$146M 28.53%
2,251,660
-545,000
-19% -$34.8M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$129M 25.27%
6,887,095
– –
MNST icon
3
Monster Beverage
MNST
$94.3B
$111M 21.67%
9,594,816
– –
MNST icon
4
PUT
Monster Beverage
MNST
$94.3B
$69.5M 13.55%
6,000,000
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$32.3M 6.31%
12,169,900
+619,506
+5% +$1.82M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$23.9M 4.67%
817,029
– –
SLTM
7
DELISTED
SOLTA MED INC (DE)
SLTM
– –
-680,723
Closed -$2.01M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Broadwood Capital held 7 positions worth $512M, up 3.1% from $497M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $35M in Q1 2014, closing 1 position and reducing 1 holding. Its most notable exit was SOLTA MED INC (DE), an estimated $2.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Staples.

Against the trend, Broadwood Capital added an estimated $1.82M to Lineage Cell Therapeutics.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q1 2014, an estimated $1.82M increase.
  • Broadwood Capital's biggest Q1 2014 reduction was QUESTCOR PHARMA INC, cutting an estimated $34.8M.
  • Broadwood Capital fully exited SOLTA MED INC (DE) in Q1 2014, selling an estimated $2.01M.
  • Broadwood Capital's ten largest holdings make up 100% of its $512M portfolio in Q1 2014.
  • Broadwood Capital opened 0 new positions and closed 1 in Q1 2014.
  • Broadwood Capital's portfolio value rose 3.1% quarter-over-quarter to $512M.

Based on Broadwood Capital's 13F filing for Q1 2014, filed 15 May 2014.